News

April 28, 2023

Phapros recorded 8.9% growth for its ethical products in the first quarter of 2023.

Phapros CEO, Hadi Kardoko, stated that the growth of Phapros' branded prescription drugs (ethical products) in the first quarter of 2023 increased by 8.9% compared to the previous year....

See More
April 11, 2023

Welcoming the 2023 Eid al-Fitr Homecoming, Phapros Prepares Tens of Thousands of Product Packages and Antimo Posts

PT Phapros Tbk is preparing various programs to enliven the 2023 Eid al-Fitr homecoming moment with its legendary product, Antimo....

See More
March 29, 2023

Current Year's Profit of PEHA Increases Significantly by 143 Percent, Analysts Evaluate Its Stock as Prospective.

PEHA recorded a sales growth of 11 percent and a significant current year's profit increase of 143 percent....

See More
March 02, 2023

Indonesia has the potential to become the largest producer of herbal medicine, and Phapros supports the development of phytopharmaceuticals.

erbal products are one of Indonesia's comparative advantages, both in terms of raw materials and cultural heritage....

See More
February 17, 2023

Phapros' exports target to reach 15 percent penetration in 2023, Economist: Investor Confidence Could Increase

The value of pharmaceutical product exports from the state-owned pharmaceutical holding company, PT Phapros Tbk, is targeted to grow in double digits. ...

See More
January 26, 2023

Bone and Teeth Medical Devices Market Future Opportunity in Indonesia and ASEAN

PT Phapros Tbk melihat kebutuhan masyarakat akan operasi implantasi pada tulang dan gigi akibat kecelakaan cukup tinggi....

See More